Abstracts

Citation

Jos Lommerse, Diana Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edward P Acosta, Edmund Capparelli, Matthew L. Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector, Betsy Smith, Mark Mirochnick. Raltegravir PK in neonates – Modeling rising and declining PK profiles of newborns exposed to raltegravir in-utero. Presented at: American Conference on Pharmacometrics (ACoP).

Citation

Jos Lommerse, Diana Clarke, Anne Chain, Han Wities, Hedy Teppler, Edward Acosta, Edmund Capparelli, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen Spector , Betsy Smith, Mark Mirochnick. Raltegravir PK in neonates– An adaptive trial design to define an appropriate regimen for neonates from birth to 6 weeks of age. Presented at: American Conference on Pharmacometrics (ACoP).

Citation

Jos Lommerse, Diana F Clarke, Anne Chain, Han Witjes, Hedy Teppler, Edmund Capparelli, Edward P Acosta, Matthew Rizk, Larissa Wenning, Thomas Kerbusch, Stephen A Spector, Betsy Smith, Mark Mirochnick. Ralteravir dosing in neonates (IMPAACT P1110) Use of Allometry and maturation in PK modeling to develop a daily dosing regimen for investigation during the first weeks of life. Presented at: Population Approach Group in Europe (PAGE) Meeting.

Citation

M Mirochnick, DE Shapiro, L Morrison, L Frenkel, N Chakhtoura, GK Siberry, B Best, MLS Cruz, BT Mmbaga, JHS Pilotto, A Violari, S Prommas, E Joao for the NICHD P1081 protocol team. Randomized trial of raltegravir-ART vs. efavirenz-ART when initiated during pregnancy. Presented at: CROI 2019; 2019 Mar 05.

Citation

Amita Gupta, Grace Montepiedra, Lisa Aaron, Gerhard Theron, Katie McCarthy, Carolyne Onyango-Makumbi, Tsungai Chipato, Gaerolwe Masheto, Katherine Shin, Bonnie Zimmer, Timothy R. Sterling, Nahida Chakhtoura, Patrick Jean-Philippe, Adriana Weinberg, IMPAACT P1078/TB APPRISE Study Team. Randomized trial of safety of isoniazid preventive therapy during or after pregnancy. Presented at: CROI 2018; 2018 Mar 07.

Citation

Mark W. Kline, M.D., Courtney V. Fletcher, Pharm.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D. Randomized Trial Of Two Saquinavir (SQV SGC)-Containing Combination Treatment Regimens In HIV-Infected Children.

Citation

Kumud K. Singh, Ping Ruan, Ph.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. RANTES-403-G/A are associated with HIV-1 disease progression and CNS impairment in children < 2 years old. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Denise L. Jacobson, Krista S. Crider, Patricia DeMarrais, Sean Brummel, Mindy Zhang, Christine Pfeiffer, Cynthia Moore, Katie McCarthy, Sikhulile Moyo, Tichaona Vhembo, Gerald Agaba Muzorah, Nahida Chakhtoura, Lameck Chinula, Shahin Lockman. RBC folate concentrations in mothers/infants randomized in pregnancy: DTG vs EFV. Presented at: CROI 2023; 2023 Feb 19.

Citation

William T. Shearer, M.D., Ph.D., Robert J. Israel, M.D. rCD4-IgG2 In HIV-1 Infected Children: Phase I/II Study.

Citation

Tichaona Vhembo, Tapiwa Mbengeranwa, Tsungai Mhembere, Lynda Stranix-Chibanda, Mutsawashe F Bwakura-Dangarembizi. Reasons for new paediatric HIV infections: findings from a cohort of HIV infected children screened at Harare Family Care Clinical Research Site. Presented at: 11th International Workshop on HIV & Pediatrics.